What the oncologist can learn from diabetes studies: Epidemiology, prevention, management, cure

Adriana Albini1, Marco Gallo2

  • 1Scientific and Technology Pole, IRCCS MultiMedica, Milano, Italy.

Insights

Cancer chemoprevention, using low-toxicity agents and lifestyle changes like increased fruit/fiber intake, shows promise in preventing cancers. More research and development are needed to match therapeutic efforts.

Area of Science:

  • Oncology
  • Preventive Medicine
  • Nutritional Science

Background:

  • Cancer therapy has seen limited progress in reducing mortality, with early diagnosis being the primary driver.
  • Cardiovascular disease mortality is declining due to prevention and biomarker identification, a model applicable to cancer.
  • Natural compounds like flavonoids show potential in managing diabetes and preventing cardiovascular diseases.

Purpose of the Study:

  • To highlight the potential of cancer chemoprevention as a valuable strategy against increasing cancer incidence.
  • To advocate for increased research and development in cancer chemoprevention, comparable to cancer therapy efforts.
  • To emphasize the need to apply successful prevention models from cardiovascular disease to oncology.

Main Methods:

  • Reviewing evidence for dietary constituents (fruits, fiber, fats) and physical activity in cancer prevention.
  • Examining the role of low-toxicity drugs and natural molecules in chemoprevention.
  • Analyzing data from epidemiological studies like the EPIC study and clinical trials.

Main Results:

  • Increased fruit and fiber intake is linked to reduced colorectal cancer risk; high-fat diets may promote certain tumors.
  • Breast, colorectal, and prostate cancers are identified as highly suitable for dietary prevention strategies.
  • Evidence supports chemoprevention's value, yet research and clinical trials in Europe are significantly underrepresented.

Conclusions:

  • Cancer chemoprevention, utilizing diet and lifestyle, offers a promising approach to combatting cancer.
  • There is a critical need to bridge the gap between cancer prevention research and cancer therapy development.
  • Systematic development of novel chemopreventive agents requires greater investment and focus, particularly in Europe.

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.1K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.6K
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
1.1K
Confounding in Epidemiological Studies01:27

Confounding in Epidemiological Studies

Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
861
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
1.4K
Stress Prevention and Stress Management Techniques II01:23

Stress Prevention and Stress Management Techniques II

Personality types, particularly Type A and Type B, significantly influence how individuals respond to stress. These personality distinctions are marked by varying levels of ambition, competitiveness, and coping styles, all of which shape an individual's resilience to stressors.
Type A Personality: Driven and Easily Stressed
Individuals with Type A personalities are often highly competitive and ambitious and operate with a strong sense of urgency. Commonly labeled as...
540